Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Organophosphate and Carbamate Poisoning - Overview
Organophosphate and Carbamate Poisoning - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Organophosphate and Carbamate Poisoning - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Organophosphate and Carbamate Poisoning - Companies Involved in Therapeutics Development
AntoXa Corp
Countervail Corp
PlantVax Inc
Shanghai Lvdao Pharmaceutical Technology Co Ltd
Organophosphate and Carbamate Poisoning - Drug Profiles
AM-132 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
galantamine hydrobromide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
LD-04001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PlantVax-1502-HN - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Recombint Butyrylcholinesterase for Carbamate and Organophosphate Poisoning - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RS-194B - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule for Organophosphate Poisoning - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Activate Acetylcholinesterase for Organophosphate Poisoning - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Agonize GABAA for Nerve Gas and Organophosphate Poisoning - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Organophosphate and Carbamate Poisoning - Dormant Projects
Organophosphate and Carbamate Poisoning - Discontinued Products
Organophosphate and Carbamate Poisoning - Product Development Milestones
Featured News & Press Releases
Feb 21, 2016: Israeli parent patent for the use of Galantamine and Antimuscarinic Agent For Organophosphorus Poisoning awarded
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Organophosphate and Carbamate Poisoning, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development for Organophosphate and Carbamate Poisoning, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Organophosphate and Carbamate Poisoning - Pipeline by AntoXa Corp, 2021
Organophosphate and Carbamate Poisoning - Pipeline by Countervail Corp, 2021
Organophosphate and Carbamate Poisoning - Pipeline by PlantVax Inc, 2021
Organophosphate and Carbamate Poisoning - Pipeline by Shanghai Lvdao Pharmaceutical Technology Co Ltd, 2021
Organophosphate and Carbamate Poisoning - Dormant Projects, 2021
Organophosphate and Carbamate Poisoning - Discontinued Products, 2021